Sentences with phrase «in basic cancer research»

The prize recognizes a scientist of international renown who has made a major scientific discovery in basic cancer research or who has made significant contributions to translational cancer research.
When Amgen, a biotech firm, tried to replicate 53 «landmark» studies in basic cancer research in 2012, it could confirm only six of them.

Not exact matches

In addition to increasing the basic understanding of how the various arms of the immune system reach their sites of differentiation and activity, these findings may aid in cancer researcIn addition to increasing the basic understanding of how the various arms of the immune system reach their sites of differentiation and activity, these findings may aid in cancer researcin cancer research.
Delegates included those interested in all aspects of lung cancer, including surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, with special sessions for nurses, allied health professionals and advocacy members.
The lack of answers to these most basic of research questions has led to, at best, a stalemate in the war on cancer, which kills more than a half million U.S. patients annually.
The trial also recorded fewer cases of lung cancer in those on the treatment, consistent with basic research findings hinting that the same inflammatory pathway may initiate or spur tumor growth.
«This basic study will allow more defined research into the genomic variations associated with colon cancer that are in the region where BMP is regulated.»
Focusing on basic research for the functional regulation of innate and adaptive immunity and on translational research for cancer immunotherapies, the National Key Laboratory of Medical Immunology has been conducting innovative research and exploration, and is becoming a rising star in the international immunology community.
So how are these huge shifts in the research firmament — multidisciplinarity, translational research, and commercialization — affecting one of the largest funders of basic biomedical science in the country, Cancer Reseresearch firmament — multidisciplinarity, translational research, and commercialization — affecting one of the largest funders of basic biomedical science in the country, Cancer Reseresearch, and commercialization — affecting one of the largest funders of basic biomedical science in the country, Cancer ResearchResearch UK?
Called the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) and funded by the drug giant Novartis, the trial also found fewer cases of lung cancer in those on the treatment, rekindling basic research findings hinting that the same inflammatory pathway may initiate or spur the growth of such tumors.
«We are looking to optimize the combinations of targeted therapies and the scheduling of those therapies so we can improve tumor shrinkage and minimize potential toxicities for a patient,» said Andrew Aplin, PhD, Associate Director for Basic Research and the Program Leader for Cancer Cell Biology and Signaling (CCBS) in the NCI - designated Sidney Kimmel Cancer Center at Jefferson Health.
Swiss Bridge Award for Research in Cancer Funding for basic cancer research, genetics and epidemiology, psycho - oncology and prevention research (total support approximating CHF 5Research in Cancer Funding for basic cancer research, genetics and epidemiology, psycho - oncology and prevention research (total support approximating CHF 500Cancer Funding for basic cancer research, genetics and epidemiology, psycho - oncology and prevention research (total support approximating CHF 500cancer research, genetics and epidemiology, psycho - oncology and prevention research (total support approximating CHF 5research, genetics and epidemiology, psycho - oncology and prevention research (total support approximating CHF 5research (total support approximating CHF 500,000).
The research, published in the Journal of Cancer Survivorship, also adds to the basic understanding of the pathophysiology of traumatic stress in general and the underlying mechanisms involved with resolving it.
Many young scientists at the basic research end of the spectrum will admit that they were initially attracted more by the desire to investigate fundamental questions in biology than to work specifically on cancer.
This question was answered in research published in the current online edition of Molecular Cell, by senior author Eileen White, PhD, associate director for basic science at the Cancer Institute of New Jersey, and colleagues.
«Research into basic workings of immune system points to way of improving therapies for cancer: Differences in wiring of «exhausted» and effective T cells indicate possible gene - editing targets.»
Understanding the physiological mechanisms that cause or, as in this case, prevent genetic instability is a basic question in Molecular Biology and Biomedicine which is of vital importance in the research against cancer, given that genetic instability is a distinctive feature of tumorous cells.
Researchers at the Institute for Basic Science (IBS) in South Korea have succeeded in developing the world's first technology to control specific protein functions in living cells by using lights, which may be useful in future cancer cell research.
Research fields are diverse, including basic research on cell proliferation, analysis of tumour cells and tissues to detect gene mutations, and identification of potential therapeutic targets inResearch fields are diverse, including basic research on cell proliferation, analysis of tumour cells and tissues to detect gene mutations, and identification of potential therapeutic targets inresearch on cell proliferation, analysis of tumour cells and tissues to detect gene mutations, and identification of potential therapeutic targets in cancer.
This advance in breast cancer research reflects the mission of Stem Cell Reports to provide an open - access forum that communicates basic discoveries in stem cell research as well as translational and clinical studies.
In its twenty years of operation, the NRSA program has made it possible for many thousands of talented individuals in the basic biomedical, behavioral, and clinical sciences to sharpen their research skills and to apply those skills to topics of special concern to the nation, such as aging, hypertension, the genetic basis of disease, acquired immune deficiency syndrome (AIDS), cancer, environmental toxicology, nutrition and health, and substance abusIn its twenty years of operation, the NRSA program has made it possible for many thousands of talented individuals in the basic biomedical, behavioral, and clinical sciences to sharpen their research skills and to apply those skills to topics of special concern to the nation, such as aging, hypertension, the genetic basis of disease, acquired immune deficiency syndrome (AIDS), cancer, environmental toxicology, nutrition and health, and substance abusin the basic biomedical, behavioral, and clinical sciences to sharpen their research skills and to apply those skills to topics of special concern to the nation, such as aging, hypertension, the genetic basis of disease, acquired immune deficiency syndrome (AIDS), cancer, environmental toxicology, nutrition and health, and substance abuse.
The aim of the Interdisciplinary Training in Cancer Research training program is to train young scientists to design and conduct research on significant problems in cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral - social sciCancer Research training program is to train young scientists to design and conduct research on significant problems in cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral - social sResearch training program is to train young scientists to design and conduct research on significant problems in cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral - social sresearch on significant problems in cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral - social scicancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral - social sciences.
The Visikol technology has applications in the fields of toxicology, pre ‐ clinical drug development, clinical diagnostics, basic research and plant biology and can be particularly valuable in fields like drug development and cancer diagnostics.
Many of these novel cancer immunotherapy approaches, which originated from basic science research in CCIR laboratories, are now being explored as new treatment modalities in patients, with a significant number advancing through clinical trials towards FDA approval.
Likewise, research specifically related to endometrial cancer is not well - represented in the basic sciences.
The Clinical Accelerator, building on 60 + years of CRI's dedication to funding the most innovative basic science in tumor immunology, enables experts to advance their most ambitious clinical and translational research ideas to cure cancer, and accelerates studies that one group or company could not do alone.
The program supports basic, pre-clinical, and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic.
Wistar is expanding its research efforts on brain cancer, both in basic and translational research.
Findings from basic research, such as studies of cancer cells in the laboratory, can ultimately define research questions to study in humans, such as helping to identify drugs to test in clinical trials.
In order to obtain the comprehensive designation, which is the highest ranking the National Cancer Institute (NCI) gives, a center must meet strict criteria that include a strong core of basic laboratory research in several fields, the ability to translate those research findings into therapies that can one day be used to treat patients, a program of high - priority clinical trials, and a commitment to community service and outreach activities related to cancer prevention and controIn order to obtain the comprehensive designation, which is the highest ranking the National Cancer Institute (NCI) gives, a center must meet strict criteria that include a strong core of basic laboratory research in several fields, the ability to translate those research findings into therapies that can one day be used to treat patients, a program of high - priority clinical trials, and a commitment to community service and outreach activities related to cancer prevention and coCancer Institute (NCI) gives, a center must meet strict criteria that include a strong core of basic laboratory research in several fields, the ability to translate those research findings into therapies that can one day be used to treat patients, a program of high - priority clinical trials, and a commitment to community service and outreach activities related to cancer prevention and controin several fields, the ability to translate those research findings into therapies that can one day be used to treat patients, a program of high - priority clinical trials, and a commitment to community service and outreach activities related to cancer prevention and cocancer prevention and control.
The grant will support basic, pre-clinical, and translational research, which will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.
Our researchers in the Center for Childhood Cancer are conducting basic science, translational and clinical research geared toward finding a cure for childhood cancer and improving the toxicity of current treatCancer are conducting basic science, translational and clinical research geared toward finding a cure for childhood cancer and improving the toxicity of current treatcancer and improving the toxicity of current treatments.
«It was extremely exciting to get this award as it will provide my lab both the resources and the stability for our ongoing efforts,» says Shaw, who is also the director of the Salk Cancer Center, which is one of just seven NCI - designated Basic Research Cancer Centers in the country.
LA JOLLA — The Salk Institute, which hosts a National Cancer Institute (NCI)-- designated cancer center and Indivumed GmbH, a world leading cancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting - edge basic and translational research in cCancer Institute (NCI)-- designated cancer center and Indivumed GmbH, a world leading cancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting - edge basic and translational research in ccancer center and Indivumed GmbH, a world leading cancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting - edge basic and translational research in ccancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting - edge basic and translational research in ccancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting - edge basic and translational research in cancercancer.
In 1999, Ashworth was appointed the first director of the ICR's Breakthrough Breast Cancer Research Centre, which is now internationally recognized, with more than 120 scientists and researchers working on aspects of the disease ranging from basic molecular and cellular biology through to translational research and clinicalResearch Centre, which is now internationally recognized, with more than 120 scientists and researchers working on aspects of the disease ranging from basic molecular and cellular biology through to translational research and clinicalresearch and clinical trials.
To take a finding in basic research, such as identifying a mutant protein that drives a particular cancer, and develop a drug that inactivates the protein and performs well in cells in the lab and in animal models can take years, if not decades.
Klemke, Wang, and their colleagues are involved in research on aspects of the basic biology behind metastasis — trying to identify the signal transduction mechanisms that lead to the spread of breast cancer cells.
This kicks off the joint Genomic Medicine Institute & Cancer Biology fundraising initiative to support basic and translational research in the two departments.
«Under her leadership, the Ben May Department has played a key role in basic biological research as well as in bridging basic cancer biology and translational research.
Other Institutions also belong to the Campus: the University of Milan; Cogentech, an IFOM - IEO consortium committed to developing leading genomic technologies (nanotechnologies, proteomics, bioinformatics, disease models), the European School of Molecular Medicine (SEMM), that organizes training in emerging sectors of Biomedicine, offering the first European PhDs in Molecular Medicine, Medical Nanotechnologies, Foundations of the Life Sciences and their Ethical Consequences; Genextra, a biotech company whose mission is to develop new therapies against cancer and aging - related disease; Biopolo, a not for profit company involved in the technological transfer of basic research to the productive system.
Research in the Immunology, Microenvironment and Metastasis program is aimed at 1) merging basic mechanistic understanding of multidisciplinary pathways of host - tumor interactions and metastatic dissemination with novel translational opportunities for diseases diagnosis and immunotherapy, as well as 2) investigating mechanisms regulating immune responses in cancer and their potential therapeutic manipulation.
From the development of insulin and transplant surgery to modern day advances, including gene therapies and cancer treatments; animals — from mice to monkeys — continue to play a crucial role in both basic and applied research.
The ITCMS program, in its 41st year, was established to provide postdoctoral fellows an interdisciplinary training experience, including basic and translational research opportunities with renowned investigators, and an extensive scope of workshops and training modules with an emphasis on cancer model systems.
Nobel Laureate in Physiology or Medicine Full Member, Basic Sciences Division Fred Hutchinson Cancer Research Center Affiliate Professor of Physiology and Biophysics University of Washington, Seattle Investigator, Howard Hughes Medical Institute
June 2013 — Byron Lee, MD, PhD, who completed his research year as part of the Urology residency program in the Genomic Medicine Institute under the mentorship of Angela Ting, PhD, won a second place Lower Memorial Award in basic science for a paper published in Cancer Rresearch year as part of the Urology residency program in the Genomic Medicine Institute under the mentorship of Angela Ting, PhD, won a second place Lower Memorial Award in basic science for a paper published in Cancer ResearchResearch.
To identify and stimulate meritorious and fundable basic science - based and translational / clinical research in breast cancer
The benefits of primate research include advances in understanding of cancer, infectious diseases, metabolic disorders, spinal cord injuries, substance abuse, and other basic biological and behavioral processes.
Through basic and clinical biomedical research and training, NCI conducts and supports research that will lead to a future in which we can prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we can not eliminate so they become manageable, chronic diseases.
The Abramson Cancer Center has more nationally recognized research on recurrent breast cancer — in the basic science labs and in the clinic — than any other center in the coCancer Center has more nationally recognized research on recurrent breast cancer — in the basic science labs and in the clinic — than any other center in the cocancerin the basic science labs and in the clinic — than any other center in the country.
Personalised medicine is becoming relevant in the treatment of lung cancer [42, 43] and may have relevance for other lung diseases, like pulmonary fibrosis, asthma and pulmonary hypertension, but disease - related basic research aimed at searching for biomarkers is needed to achieve personalised and patient - specific treatments for lung diseases.
a b c d e f g h i j k l m n o p q r s t u v w x y z